For the Quarter Ending December 2025
APAC
• In China, the Cefaclor Price Index rose by 1.39% quarter-over-quarter, supported by export procurement patterns.
• The average Cefaclor price for the quarter was approximately USD 218833.33/MT, based on export averages.
• Cefaclor Spot Price remained firm as contracted volumes constrained prompt availability despite balanced export-oriented inventories.
• Cefaclor Production Cost Trend stayed elevated due to coal-linked steam tariffs and steady utility charges.
• Cefaclor Demand Outlook remains constructive driven by predictable winter offtake and targeted replenishment from importers.
• Cefaclor Price Forecast indicates narrow near-term banding with upward risk if environmental inspections trigger plant outages.
• Cefaclor Price Index movement reflected steady exporter confidence, constrained spot availability, and sustained procurement momentum.
• Operating rates remained high while Shanghai port scheduling eased congestion, maintaining reliable outbound flows and exports.
Why did the price of Cefaclor change in December 2025 in APAC?
• Sustained high operating rates and limited medium-scale reactor idlings tightened prompt availability, supporting marginal price increase.
• Elevated coal-linked steam and utility tariffs maintained conversion costs, preventing downward pressure on producer margins.
• Consistent export procurement, importer replenishment, and manageable Shanghai port scheduling balanced supply-demand, limiting marginal volatility.
Europe
• In Germany, the Cefaclor Price Index rose by 1.38% quarter-over-quarter, reflecting import-cost increases from Asia.
• The average Cefaclor price for the quarter was approximately USD 218918.33/MT across CFR Hamburg deliveries.
• Cefaclor Spot Price strengthened as Germany's Price Index absorbed FOB increases from China and India
• Cefaclor Price Forecast signals firmness, supported by Asian supply constraints and Cefaclor Production Cost Trend
• Cefaclor Demand Outlook remains steady, with formulators making routine purchases supporting the Germany Price Index
• Inventory levels at Hamburg remained moderate-to-low, limiting upside and keeping the Cefaclor Price Index measured.
• Port congestion encouraged adherence to schedules, reducing spot availability and tightening the Cefaclor Spot Price
• Export demand from Asia plus year-end environmental audits constrained flows, reinforcing the Cefaclor Price Forecast
Why did the price of Cefaclor change in December 2025 in Europe?
• Asian supply tightened due to intensified inspections and year-end production scheduling reducing available export volumes
• Freight surcharges remained stable, so landed costs rose from higher FOB levels and constrained availability
• Domestic demand stayed steady, limiting offtake; supply-side constraints transmitted directly into the German Price Index
North America
• In USA, the Cefaclor Price Index rose by 1.39% quarter-over-quarter, reflecting procurement and steady demand.
• The average Cefaclor price for the quarter was approximately USD 218933.33/MT, reflecting import-weighted landed costs.
• Cefaclor Spot Price remained muted as West Coast inventories and planned imports maintained balanced availability.
• Cefaclor Price Forecast suggests a narrow trading range supported by steady imports and easing freight.
• Cefaclor Production Cost Trend showed upward pressure from higher 7-ACA costs passed through Asian suppliers.
• Cefaclor Demand Outlook remains steady with paediatric prescriptions and formulators replenishing moderate inventories for production.
• Cefaclor Price Index stability reflected disciplined purchasing, shipments, and absence of regulatory disruptions this quarter.
• Inventory cushioning and late freight relief limited volatility, keeping Cefaclor supply sufficient for routine demand.
Why did the price of Cefaclor change in December 2025 in North America?
• Consistent Chinese and Indian exports maintained supply, preventing significant December upward pressure on Cefaclor prices.
• Refrigerated freight rates fell late, easing logistics costs, but most December bookings completed before decline.
• Stable seasonal paediatric prescriptions and formulators' planned replenishment sustained demand, keeping market balanced and predictable.
For the Quarter Ending September 2025
North America
• In USA, the Cefaclor Price Index fell by 2.40% quarter-over-quarter, reflecting mild post-restocking market softness.
• The average Cefaclor price for the quarter was approximately USD 215931.00/MT, reported by trade handlers.
• Cefaclor Spot Price softened as frontloaded imports and normalized logistics reduced urgent spot purchasing across channels.
• Cefaclor Price Forecast indicates modest volatility with seasonal restocking and tariff uncertainty affecting near-term trajectories.
• Cefaclor Production Cost Trend showed upward pressure from inflationary logistics and handling, partially offset by freight stabilization.
• Cefaclor Demand Outlook remains cautious as buyers pause after aggressive pre-tariff purchasing, moderating short-term off-take.
• Cefaclor Price Index movements reflected inventory normalization and selective distributor discounts to clear aging stocks efficiently.
• Cefaclor Spot Price and inventory balances influenced export demand patterns and distributor replenishment timing across the coast.
Why did the price of Cefaclor change in September 2025 in North America?
• Import volumes decreased after July frontloading, releasing supply pressure and easing upward price momentum.
• Port congestion eased and logistics costs declined, reducing landed costs and lowering price pressure.
• Buyers delayed purchases amid tariff uncertainty, diminishing short-term demand and prompting supplier price concessions.
APAC
• In China, the Cefaclor Price Index fell by 2.382% quarter-over-quarter, reflecting weaker export demand and logistics.
• The average Cefaclor price for the quarter was approximately USD 215833.33/MT reflecting shipment patterns and inventories.
• Cefaclor Spot Price softened in August as front-loaded exports reduced buying and elevated onshore inventories.
• Cefaclor Price Forecast suggests volatility; the Price Index signals slight recovery as shipments normalize Q4.
• Cefaclor Production Cost Trend showed upward pressure from freight and weather disruptions, increasing unit costs.
• Cefaclor Demand Outlook remains subdued post-frontloading; distributors pause purchases, though year-end restocking could revive activity later.
• Cefaclor Price Index movements reflected balanced supply demand; port delays constrained flows while inventories stayed elevated.
• Major Chinese producers kept calibrated output, limiting spot availability while avoiding overproduction amid tariff uncertainty.
Why did the price of Cefaclor change in September 2025 in APAC?
• Export demand remained muted after front-loaded shipments, reducing new orders and softening spot market pricing.
• Freight and PSS removal lowered export costs, enabling suppliers to ease offers and reduce the Price Index.
• Port disruptions and delays constrained flows, prompting cautious purchasing and limiting upward pressure on prices.
Europe
• In Germany, the Cefaclor Price Index fell by 2.38% quarter-over-quarter in Q3 2025, port congestion.
• The average Cefaclor price for the quarter was approximately USD 215937.33/MT, reported by CFR Hamburg sources.
• Shipping delays tightened supply and pushed the Cefaclor Spot Price higher, reflecting logistics costs and uncertainty.
• Forward curves and market commentary inform the Cefaclor Price Forecast suggesting volatility through autumn months.
• Elevated freight and rerouting increased expenses, tightening the Cefaclor Production Cost Trend over the quarter.
• Downstream purchasing patterns shaped the Cefaclor Demand Outlook with cautious restocking and reduced spot buying evident.
• Inventories at distributors remained adequate, moderating the Cefaclor Price Index despite localized shortages and shipment delays.
• Major importer operations stabilized, limiting upside; near term interventions likely to anchor the Cefaclor Price Index.
Why did the price of Cefaclor change in September 2025 in Europe?
• Severe port congestion and Rhine low water levels delayed imports, compressing supply and raising costs.
• Higher freight surcharges and rerouting increased procurement expenditure, squeezing margins and influencing payable prices overall.
• Cautious buyer behavior and existing stocks reduced spot demand, slightly easing upward pressure on prices.
For the Quarter Ending June 2025
North America
• The Cefaclor Price Index in the USA showed marginal growth across Q2, rising from USD 220,900/MT in April to USD 221,120/MT in May, and USD 221,687/MT in June, reflecting a cumulative quarterly increase of 0.72%.
• In April, the product spot price edged higher as a response to the newly imposed 145% tariff on Chinese goods, triggering pre-tariff stockpiling and shifting product production cost trends upward due to elevated landed costs and complex logistics.
• April's product demand outlook remained steady, bolstered by slowing inflation (CPI at 2.3%) and improved consumer confidence, which encouraged forward procurement strategies across the pharmaceutical supply chain.
• In May, Cefaclor prices experienced a 0.10% Price Index rise due to continued frontloading driven by a 90-day tariff suspension, with heightened shipping activity and the onset of Peak Season Surcharges (PSS) impacting overall cost structure.
• Port congestion and extended container turnaround times in May added subtle upward pressure to product spot prices, while the threat of June’s General Rate Increase (GRI) led to moderate stockpiling.
• May's product demand outlook was reinforced by positive business sentiment amid inflation recovery, motivating distributors to build inventory in anticipation of future logistics challenges.
• In June, the Price Index increased another 0.26%, primarily shaped by proactive importer behavior amid persistent trade uncertainty and inflation-linked supply chain costs.
• June also saw advanced shipments of Q3 and Q4 inventories, subtly tightening supply and reinforcing an upward trajectory in product production cost trend.
• Domestic demand for Cefaclor stayed consistent in June, but a shift toward anticipatory procurement amid inflation and tariff speculation maintained modest pressure on availability and pricing.
• For July 2025, the Cefaclor price forecast points to a slight decrease, as post-frontloading restocks ease, demand softens, and suppliers reduce prices to remain competitive—indicating a temporary dip in the product spot price and a more subdued product demand outlook.
APAC
• The Price Index for Cefaclor in China rose modestly across Q2 2025, moving from USD 220,800/MT in April to USD 221,500/MT in June, reflecting a cumulative quarterly increase of 0.68%.
• In April, the Cefaclor spot price saw a moderate uptick as domestic and export buyers ramped up inventory replenishment, reacting to future supply stability concerns. This shift supported a bullish Product price forecast.
• Despite a slowing manufacturing PMI of 49.0, supply conditions remained tight due to depleted March inventories, pushing the Price Index up as lean stocks and procurement urgency drove short-term gains.
• Product demand outlook strengthened in April, led by consistent pharmaceutical consumption and revived exports to Asia and Europe.
• In May, the Cefaclor Price Index increased only slightly by 0.09%, as production normalized after the Labour Day pause and supply remained robust.
• Export logistics became more complex due to a 27% hike in container freight rates, though Cefaclor sellers avoided significant price shifts due to steady product flow and managed shipping capacity.
• The Product spot price remained largely stable in May as buyers showed restrained yet consistent ordering behavior, particularly from the U.S., Europe, and Asia.
• In June, the Price Index rose again by 0.23%, driven by frontloaded export orders following a temporary U.S. tariff suspension. Shipping costs increased further, affecting the product production cost trend.
• Chinese producers scaled up slightly to meet export demand but remained cautious with capacity, wary of the post-suspension volatility expected in Q3.
• In July 2025, Cefaclor prices are likely to decrease slightly as demand softens post-advanced ordering, while supply remains cautiously stable amid subdued domestic expansion.
Europe
• The Cefaclor Price Index in Germany showed a steady uptrend in Q2, moving from USD 220,887/MT in April to USD 221,610/MT in June, marking a quarterly gain of approximately 0.69%.
• In April, the product spot price rose moderately due to logistics disruptions from Easter holidays and port congestion at Hamburg and Rotterdam.
• Trade redirection from the U.S. to Europe amid new tariffs created a temporary supply strain, affecting product demand outlook and increasing warehouse activity in Germany.
• The Price Index increased by 0.36% in April, supported by firmer downstream demand and precautionary restocking amid tighter delivery timelines.
• May saw a marginal Price Index uptick of 0.09%, with stable product spot price movement as suppliers managed steady inventory flows despite persistent freight congestion.
• Importers in May maintained regular procurement patterns, avoiding stockpiling while responding cautiously to shipping constraints, keeping the product demand outlook balanced.
• In June, further port congestion and Rhine River low water levels caused extended lead times, prompting early restocking and a Price Index increase of 0.24%.
• Despite inflation cooling to 2%, delayed shipments from Asia prompted cautious optimism and mild price hikes to ensure timely deliveries.
• The product price forecast for July 2025 indicates a modest decrease, as demand softens post-restocking and supply disruptions ease.
• Stabilization in logistics and improved freight schedules are likely to reduce procurement costs, reflecting a downward product production cost trend.
For the Quarter Ending March 2025
North America
In Q1 2025, Cefaclor prices in the USA experienced notable fluctuations. January saw moderate price increases driven by preemptive purchasing ahead of a 10% tariff on Chinese goods and the Chinese Lunar New Year, which created short-term supply pressures. Rising energy costs and congestion at Los Angeles ports added to the strain, elevating operational expenses and contributing to price hikes.
February recorded a slight price increase as U.S. buyers anticipated additional tariffs and continued to accelerate procurement, maintaining moderate supply-side pressures. However, improved port operations in Asia helped alleviate some supply chain disruptions.
In March, prices declined significantly due to weak demand, oversupply, and growing trade uncertainties, particularly the weakening of the U.S. dollar and looming tariffs on imports from both China and India. Distributors, holding high inventory levels, faced pressure to offload excess stock, resulting in aggressive pricing strategies. These dynamics led to a price drop despite ongoing tariff concerns.
Overall, Q1 saw mixed price movements, with external factors like tariffs and supply chain disruptions playing central roles.
Asia Pacific
In Q1 2025, Cefaclor prices in China followed a slightly upward then downward trajectory, reflecting shifts in supply-demand dynamics and external factors. In January, prices rose modestly due to steady demand from the pharmaceutical and healthcare sectors, coupled with limited production capacity ahead of the Lunar New Year. Suppliers cautiously adjusted their strategies in anticipation of potential supply disruptions, particularly driven by U.S. tariff concerns. In February, prices saw a slight increase again, as manufacturing disruptions during the Lunar New Year led to supply shortages. Meanwhile, steady demand from key sectors and anticipatory buying ahead of potential U.S. tariff hikes put pressure on the market. However, by March, prices began to decline, driven by an increase in production, aided by government measures, and weaker demand as buyers had already stocked up. Additionally, the strengthening yuan reduced export competitiveness, while concerns over trade tensions and port congestion led to a slowdown in purchases. Overall, the quarter saw price fluctuations influenced by supply chain adjustments, external tariffs, and shifting demand.
Europe
In Q1 2025, Cefaclor prices in Germany fluctuated, driven by supply and demand dynamics. In January, prices increased moderately due to improved business sentiment and optimism about the economic outlook. Demand from the healthcare and pharmaceutical sectors rose, supported by early stockpiling ahead of the Lunar New Year. Loosening monetary policy also boosted consumer sentiment, further supporting the price increase. In February, however, prices declined as favorable import conditions, such as a stronger Euro and lower ocean freight rates, allowed for cost-effective imports. This, combined with weak demand amid political and economic uncertainty, led to reduced urgency for new orders. Suppliers responded to subdued demand and increased competition by cutting prices. In March, the downward trend continued as oversupply persisted, supported by low freight costs and strong Euro-based imports. Demand stagnated after the Chinese New Year, and many buyers focused on clearing inventories instead of placing new orders. The combination of ample supply and weakened demand reinforced the downward pressure on prices through the quarter.
